SEC Form 4 · accession 0001567619-18-004305
Avalo Therapeutics, Inc. · AVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Randal Jones
10% Owner
Period of report
Aug 13, 2018
Accepted (ET)
Oct 18, 2018 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534120
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 13, 2018 | M | 1,270 | $3.20 | A | 1,270 | D | |
| Common Stock | Aug 13, 2018 | S | 1,270 | $3.98 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.20 | Aug 13, 2018 | M | 1,270 | D | Dec 31, 2017 | Aug 15, 2018 | Common Stock | 1,270 | 0 | D |